Biotech SMEs struggle every day with analyzing large sequencing datasets at the rate they're being generated, especially without a bioinformatician on-hand.

We solve it with biobot, a no-code, end-to-end workflow for state-of-the-art sequencing analysis so scientists can go from raw data to biological insight in minutes, not days.

And we know how, because of our career-long experience in bioinformatics, software development and product engineering. We're on a mission to empower every scientist to analyze their data independently, and we're starting with single-cell transcriptomics.